KARBINAL ER Drug Patent Profile
✉ Email this page to a colleague
When do Karbinal Er patents expire, and what generic alternatives are available?
Karbinal Er is a drug marketed by Aytu and is included in one NDA. There are two patents protecting this drug.
This drug has twenty-one patent family members in fourteen countries.
The generic ingredient in KARBINAL ER is carbinoxamine maleate. There are seven drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the carbinoxamine maleate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Karbinal Er
A generic version of KARBINAL ER was approved as carbinoxamine maleate by GENUS on March 19th, 2003.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for KARBINAL ER?
- What are the global sales for KARBINAL ER?
- What is Average Wholesale Price for KARBINAL ER?
Summary for KARBINAL ER
International Patents: | 21 |
US Patents: | 2 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 62 |
Patent Applications: | 1,287 |
Drug Prices: | Drug price information for KARBINAL ER |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for KARBINAL ER |
DailyMed Link: | KARBINAL ER at DailyMed |
Pharmacology for KARBINAL ER
Drug Class | Histamine-1 Receptor Antagonist |
Mechanism of Action | Histamine H1 Receptor Antagonists |
US Patents and Regulatory Information for KARBINAL ER
KARBINAL ER is protected by two US patents.
Patents protecting KARBINAL ER
Modified release formulations containing drug-ion exchange resin complexes
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Modified release formulations containing drug--ion exchange resin complexes
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aytu | KARBINAL ER | carbinoxamine maleate | SUSPENSION, EXTENDED RELEASE;ORAL | 022556-001 | Mar 28, 2013 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Aytu | KARBINAL ER | carbinoxamine maleate | SUSPENSION, EXTENDED RELEASE;ORAL | 022556-001 | Mar 28, 2013 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for KARBINAL ER
See the table below for patents covering KARBINAL ER around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
South Korea | 101495146 | ⤷ Sign Up | |
Australia | 2007227569 | Modified release formulations containing drug-ion exchange resin complexes | ⤷ Sign Up |
South Korea | 20080108520 | MODIFIED RELEASE FORMULATIONS CONTAINING DRUG - ION EXCHANGE RESIN COMPLEXES | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |